Bimonthly, Established in 1959
Open access journal

Migraine Treatment

These articles collectively offer insights into both longstanding and innovative treatments for migraine, emphasizing a range of pharmacological options and the promising direction of targeted therapies.

Title: Current and emerging evidence-based treatment options in chronic migraine: a narrative review

Authors: Elio Clemente Agostoni, Piero Barbanti, Paolo Calabresi, Bruno Colombo, Pietro Cortelli, Fabio Frediani, Pietrangelo Geppetti, Licia Grazzi, Massimo Leone, Paolo Martelletti, Luigi Alberto Pini, Maria Pia Prudenzano, Paola Sarchielli, Gioacchino Tedeschi, Antonio Russo; Italian chronic migraine group

Description: This review explores both traditional and new treatment strategies for chronic migraine. It delves into the effectiveness of OnabotulinumtoxinA and topiramate, backed by strong evidence for their use in prevention. Additionally, the article considers emerging therapies and non-invasive neurostimulation, alongside complementary approaches like acupuncture and nutraceuticals.(pubmed)

Title: Melatonin as a treatment for migraine sufferers: a systematic review

Authors: Oka Adnyana, Clarissa Tertia et al.

Description: This systematic review assesses the effectiveness of melatonin in migraine treatment across several studies. The findings suggest potential benefits in reducing migraine frequency and improving sleep quality, comparing favorably against placebo and other common migraine medications. (SpringerOpen)

Title: Advances in migraine treatment

Authors: George R Nissan 1, Merle L Diamond

Description: Highlighting new developments in migraine management, this article discusses the shift towards targeted treatments like CGRP monoclonal antibodies. It underscores the potential of these treatments to offer effective prevention with fewer side effects compared to traditional therapies. (pubmed)

Title: Migraine: Advances in the Pathogenesis and Treatment

Authors: Alexandru Vlad Ciurea

Description: This comprehensive review delves into the complex pathogenesis of migraine and discusses the role of calcitonin gene-related peptide (CGRP) in the development of migraine symptoms. The review evaluates the efficacy of CGRP inhibitors and explores neuromodulation techniques, offering a detailed analysis of both traditional treatments and innovative therapeutic strategies for migraine management​ (MDPI)​.

Title: What’s New in Migraine Treatment

Authors: Kathleen Digre, MD

Description: This article provides an update on recent advancements in migraine treatment, focusing on CGRP monoclonal antibodies and gepants. It describes the transition from general-use medications to migraine-specific treatments designed to prevent migraine by targeting specific proteins. The article also discusses the emergence of new devices and therapeutic strategies that are shaping modern migraine care​ (University of Utah Healthcare)​.